Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check7 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, signaling a minor update to the ClinicalTrials.gov entry. This change does not modify the study details, eligibility criteria, or other substantive content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label was updated to v3.6.3, indicating a new version of the page. The change is limited to metadata/versioning and does not alter the study information displayed.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor software update to the page.SummaryDifference0.1%

- Check50 days agoChange DetectedNew navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a refreshed Intervention/Treatment heading appear with a new Revision: v3.6.0 label, while older items (Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5) were removed.SummaryDifference1%

- Check57 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous version. This reflects a minor update to the page's documentation/versioning rather than substantive study content.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new build of the page rendering. This appears to be an internal versioning update rather than a modification to the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.